Welcome to Autifony Therapeutics

Autifony Therapeutics: developing new drugs to treat hearing disorders, tinnitus, age related hearing loss & schizophrenia. Clinical trials recruiting now Autifony Therapeutics Limited: developing new drugs to treat hearing disorders, tinnitus, age related hearing loss and schizophrenia. Clinical trials recruiting now Autifony Therapeutics Ltd: aiming to develop new drugs to treat hearing disorders, tinnitus, age related hearing loss & schizophrenia. Clinical trials running now Autifony Therapeutics: working to develop new drug treatments for hearing disorders, tinnitus, age related hearing loss & schizophrenia. Clinical trials recruiting now Autifony Therapeutics aims to develop new drugs to treat hearing disorders using pioneering science

Autifony Therapeutics aims to develop new drugs to treat hearing disorders using pioneering science

Hearing disorders affect a significant proportion of the population, and while devices such as hearing aids and cochlear implants can ease the problems for some, many people suffer silently. As well as causing social isolation and distress, hearing loss also brings with it a considerable economic cost to society, with increased risk of unemployment, the need for carer support, and other costs.

By targeting specific ion channels which regulate neuronal activity within the auditory system, our new drugs will help to improve hearing and reduce symptoms associated with hearing loss, such as tinnitus.

Autifony‚Äč are also using their pioneering approach to develop novel treatments for other serious disorders of the central nervous system, such as schizophrenia.